-
Taxonomy & unit
-
ifrs-full: CNY and USD
-
Summary
-
Connect Biopharma Holdings Ltd annual Research And Development Expense history and growth rate from 2021 to 2022.
- Connect Biopharma Holdings Ltd annual Research And Development Expense for 2022 was $93.6M, a 15.3% increase from 2021.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)